Zobrazeno 1 - 10
of 639
pro vyhledávání: '"Kalfoglou"'
Autor:
Lisa Davis, Nathan Riccitelli, Nancy Valencia, Irene L. Ch’en, Shabnam Tangri, Jennifer L. Brogdon, Creton Kalfoglou, Karen Thudium Mueller, Reinhold Pollner
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 535-541 (2021)
Chimeric antigen receptor (CAR)-T cell therapies reprogram T cells to engage and eliminate cancer cells. Patients’ T cells are transduced in vitro using lentiviral or retroviral vectors containing a CAR transgene. Following infusion, CAR-T cells ex
Externí odkaz:
https://doaj.org/article/2b681f0aeb284e3f903d79b38dc6b465
Autor:
Kalfoglou, I.
1). After presenting an in depth analysis of the field of ontologies and software testing as conceived and implemented by the software engineering and artificial intelligence communities (chapter 2), we discuss an approach which enabled us to deploy
Externí odkaz:
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.653180
Autor:
Sotirios Kalfoglou
Publikováno v:
Lectio Socialis, Vol 3, Iss 1, Pp 1-8 (2019)
Security is a complicated concept where people have to be secure and also feel it. Serious risk calculations determine the fact but also the feeling has to be included in the policy development. Because people are generally are scared by spectacular
Externí odkaz:
https://doaj.org/article/f06c7707ce3d47c7a9685c3786e9399f
Autor:
Sotirios Kalfoglou
Publikováno v:
Lectio Socialis, Vol 3, Iss 1, Pp 1-8 (2019)
Güvenlik, insanlara sağlanan ancak aynı zamanda hissedilebilmesi gereken karmaşık bir kavramdır. Güvenlik gereksinim oranı, risk hesaplamaları ile gerçekleşirken politika oluşturmak kişi psikolojisi ve duygularını da hesaba katarak
Externí odkaz:
https://doaj.org/article/02fa8dbe0ad647b283c23ef1b367acc8
Publikováno v:
Istanbul Yeni Yuzyil Universitesi, Yeni Yuzyil Journal of Medical Sciences.
Gerek özel gerekse ceza hukuku bakımından, adli veya te- davi amaçlı örnek alımlarında ilgili kişinin onamı önemli- dir. Amaç insan üzerinde deney yapılmasının önlenmesi- nin ötesinde kişilerin haklarını korumak, onları risk vey
Autor:
Stephan A. Grupp, Gabor Kari, Harald J. Maier, Karen Thudium Mueller, Edward R. Waldron, Kevin Nguyen, Creton Kalfoglou, Heather E. Stefanski, Jochen Buechner, Andre Baruchel, Peter Bader, G. Doug Myers, Tim Driscoll, Gregory A. Yanik, Hidefumi Hiramatsu, Michael W. Boyer, Susana Rives, Muna Qayed, Theodore W. Laetsch, Shannon L. Maude, Xia Han, Michael A. Pulsipher
Supplementary Data from Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f640dfe63ee4f38cc502810e22e2845
https://doi.org/10.1158/2643-3230.22544129
https://doi.org/10.1158/2643-3230.22544129
Autor:
Stephan A. Grupp, Gabor Kari, Harald J. Maier, Karen Thudium Mueller, Edward R. Waldron, Kevin Nguyen, Creton Kalfoglou, Heather E. Stefanski, Jochen Buechner, Andre Baruchel, Peter Bader, G. Doug Myers, Tim Driscoll, Gregory A. Yanik, Hidefumi Hiramatsu, Michael W. Boyer, Susana Rives, Muna Qayed, Theodore W. Laetsch, Shannon L. Maude, Xia Han, Michael A. Pulsipher
We assessed minimal residual disease (MRD) detection and B-cell aplasia after tisagenlecleucel therapy for acute lymphoblastic leukemia (ALL) to define biomarkers predictive of relapse (N = 143). Next-generation sequencing (NGS) MRD detection >0 in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a79c0ec9a1437e58820595e137dfe73
https://doi.org/10.1158/2643-3230.c.6550538.v1
https://doi.org/10.1158/2643-3230.c.6550538.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gabor Kari, André Baruchel, Hidefumi Hiramatsu, Peter Bader, Timothy A. Driscoll, Jochen Buechner, Muna Qayed, Kevin Nguyen, Xia Han, Shannon L. Maude, G. Doug Myers, Michael A. Pulsipher, Gregory A. Yanik, Stephan A. Grupp, Edward Waldron, Creton Kalfoglou, Karen Thudium Mueller, Susana Rives, Theodore W. Laetsch, Harald J. Maier, Michael Boyer, Heather E. Stefanski
Publikováno v:
Blood Cancer Discovery. 3:66-81
We assessed minimal residual disease (MRD) detection and B-cell aplasia after tisagenlecleucel therapy for acute lymphoblastic leukemia (ALL) to define biomarkers predictive of relapse (N = 143). Next-generation sequencing (NGS) MRD detection >0 in b